Ligand Pharmaceuticals Incorporated (LGND) Stock Price & Financial Analysis
Ligand Pharmaceuticals Incorporated Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Ligand Pharmaceuticals Incorporated
What is the current stock price for LGND?
As of the latest trading session, LGND stock trades at $199.59. The 52-week range is $93.58–$227.92, with a day range of $194.67–$201.42.
What is the P/E ratio for LGND?
Ligand Pharmaceuticals Incorporated's trailing P/E ratio is 33.9, meaning investors pay $33.9 for every $1 of annual earnings. Ligand Pharmaceuticals Incorporated operates in the Healthcare sector.
Does LGND pay dividends?
Ligand Pharmaceuticals Incorporated does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for LGND?
Based on 4 analysts, the consensus for LGND is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of LGND?
Ligand Pharmaceuticals Incorporated's market capitalization is $4.22B, classifying it as a mid-cap company. Ligand Pharmaceuticals Incorporated operates in the Healthcare sector within the Biotechnology industry.